Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-409-0 | CAS number: 65104-06-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 October 2018 - 31 January 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- The study integrity was not adversely affected by the deviations.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Diammonium dihydroxybis[lactato(2-)-O1,O2]titanate(2-)
- EC Number:
- 265-409-0
- EC Name:
- Diammonium dihydroxybis[lactato(2-)-O1,O2]titanate(2-)
- Cas Number:
- 65104-06-5
- Molecular formula:
- C6H18N2O8Ti
- IUPAC Name:
- Diammonium dihydroxybis[lactato(2-)-O1,O2]titanate(2-)
- Test material form:
- solid: particulate/powder
1
Method
- Target gene:
- Gene of histidine in Salmonella typhimurium and gene of tryptophan in Escherichia coli
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: rfa w all mutation and delation of uvr B gene: presence of R factor plasmid pKM101 in strains TA98 and TA 100 to further increase the sensitivity of these strains to some mutagens
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat-liver homogenate activation system (S-9)
- Test concentrations with justification for top dose:
- The test substance was tested in the tester strain TA100 with concentrations of (a) 50, (b) 100, (c) 200, (d) 400, (e) 800, (f) 1600, (g) 3200 and (h) 5000 µg/plate in the absence and presence of S9-mix.
Based on the results of the dose range finding test, the test item was tested with the concentrations of a) 50, (b) 158, (c) 500, (d) 1581, and (e) 5000 µg/plate in the absence and presence of S9-mix in two mutation assays. The first mutation experiment was performed using the direct plate incorporation method and the second mutation experiment was conducted using the pre-incubation method. - Vehicle / solvent:
- Sterile water
- Justification for choice of solvent/vehicle:
Water is one of the vehicles compatible with this test system. Hence, based on the results of the solubility test, SW was selected as the vehicle of choice in the mutation assay.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 4 ug/plate
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- used for assay w ith metabolic activation for all tester strains
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 1 µg/plate
- Positive control substance:
- sodium azide
- Remarks:
- used for assay w ith metabolic activation for strain TA 1535
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2 µg/plate
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- used for assay w ith metabolic activation for strain TA 98
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 50 µg/plate
- Positive control substance:
- 9-aminoacridine
- Remarks:
- used for assay with metabolic activation for strain TA1537
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 4 µg/plate
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- used for assay w ith metabolic activation for strain WP2uvrA
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: Triplicate
- Number of independent experiments: 2
METHOD OF APPLICATION:
In the initial mutation assay, which was a plate incorporation mode of exposure, the bacterial suspensions were exposed to the test item, vehicle and the positive controls in the presence and absence of an exogenous metabolic activation system. These bacterial suspensions were then mixed with overlay agar and plated immediately onto minimal medium viz., his- for Salmonella typhimurium and trp- for Escherichia coli, respectively.
In the confirmatory assay, which was a pre-incubation mode of exposure, the test constituents were mixed with the bacteria inside a tube, incubated in an incubator shaker, mixed with overlay agar and plated immediately onto minimal medium his- for Salmonella typhimurium and trp- for Escherichia coli, respectively.
DURATION
- Exposure duration: 67 hrs
-Temperature: 37.0 ± 1.0 degrees
NUMBER OF REPLICATIONS: three
DETERMINATION OF CYTOTOXICITY
- Method: The condition of the bacterial background lawn was evaluated for evidence of the test item toxicity using the code system
Code Description Characteristics
0 Absent Distinguished by a complete lack of any micro-colony lawn over > 90% of the plate compared with the vehicle control plates
1+ SeverelyReduced Distinguished by an extreme thinning of the micro-colony lawn resulting in an increase in the size of the micro-colonies compared with the vehicle control plates such that the micro-colony lawn is visible to the unaided eye as isolated colonies
2+ Moderately reduced Distinguished by a marked thinning of the micro-colony lawn resulting in a pronounced increase in the size of the micro-colonies compared with the vehicle control plates
3+ Slightlyreduced Distinguished by a noticeable thinning of the micro-colony lawn and possibly a slight increase in the size of the micro-colonies compared with the vehicle control plates
4+ Normal Distinguished by a healthy background lawn comparable to vehicle control plates
NP Non-interfering precipitate Distinguished by precipitate on the plate that is visible to the naked eye and is not interfering with the evaluation of bacterial lawn
IP Interfering precipitate Distinguished by precipitate on the plate that is visible to the naked eye and is interfering with the evaluation of bacterial lawn
OP Obscured by particulate The background lawn cannot be accurately evaluated due to microscopic test item particulate
NPO No precipitation observed Precipitation not observed - Evaluation criteria:
- To determine a positive result, there should be a dose related increase in the mean revertants per plate of at least one tester strain over a minimum of two increasing concentrations of the test item either in the presence or absence of the metabolic activation system.
The test will be judged positive, if the increase in mean revertants at the peak of the dose response is equal to or greater than 2 times the mean vehicle control value for strains TA98, TA100 and WP2uvrA (pKM101) or equal to or greater than 3 times the mean vehicle control value for strains TA1535 and TA1537.
An equivocal response is a biologically relevant increase in a revertant count that partially meets the criteria for evaluation as positive. This could be a dose responsive increase that does not achieve the respective threshold cited above or a non-dose responsive increase that is equal to or greater than the respective threshold cited. A response will be evaluated as negative, if it is neither positive nor equivocal.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: The test item did not cause precipitation on the basal agar plates at any of the tested doses.
RANGE-FINDING/SCREENING STUDIES: The test item did not show toxicity in any of the tested doses as the intensity of the bacterial background lawn as well as the mean number of revertant colonies was comparable to the vehicle control plates. Based on these observations, the OECD 471-recommended highest test dose of 5000 µg/plate was tested in the mutation assay.
COMPARISON WITH HISTORICAL CONTROL DATA: Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 demonstrated the requirement of histidine amino acid for their growth. Escherichia coli strain WP2uvrA (pKM101) demonstrated the requirement of tryptophan amino acid for its growth. Ampicillin resistance was demonstrated by the strains TA98, TA100 and WP2uvrA (pKM101) which carry R-factor plasmids. The presence of characteristic mutations like the rfa mutation was demonstrated by all the Salmonella typhimurium strains by their sensitivity to crystal violet. The uvrA mutation in the
Escherichia coli strain and the uvrB mutation in the Salmonella typhimurium strains were demonstrated through their sensitivity to ultraviolet light. Finally, all these tester strains produced spontaneous revertant colonies which were within the frequency ranges of the test facility’s historical control data.
Any other information on results incl. tables
TABLE 1. Summary Results of Initial Mutation Assay in the Presence of Metabolic Activation
Treatment (µg/plate) |
No. of revertants/platea |
||||||||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA(pKM101) |
|||||||||||
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
|
SW |
26 |
2 |
NA |
97 |
6 |
NA |
14 |
1 |
NA |
12 |
2 |
NA |
141 |
6 |
NA |
50 |
24 |
2 |
0.91 |
100 |
7 |
1.04 |
13 |
1 |
0.90 |
10 |
2 |
0.83 |
134 |
7 |
0.95 |
158 |
26 |
3 |
0.99 |
95 |
7 |
0.98 |
13 |
1 |
0.93 |
10 |
2 |
0.89 |
134 |
8 |
0.95 |
500 |
23 |
1 |
0.90 |
96 |
3 |
0.99 |
13 |
2 |
0.95 |
10 |
1 |
0.83 |
142 |
5 |
1.01 |
1581 |
25 |
2 |
0.95 |
90 |
6 |
0.93 |
13 |
1 |
0.90 |
9 |
1 |
0.77 |
136 |
6 |
0.96 |
5000 |
24 |
2 |
0.91 |
94 |
5 |
0.98 |
13 |
1 |
0.93 |
11 |
1 |
0.94 |
142 |
4 |
1.01 |
Positive control |
571c |
19c |
21.95c |
873c |
26c |
9.03c |
169c |
17c |
12.10c |
175c |
26c |
15.03c |
567d |
20d |
4.02d |
aValues are means of three replicatescalculated from individual values of Appendix 3and are rounded off to the nearest whole number bRatio of treated/Vehicle control (mean revertants per plate). The presentation was made using the mean values with decimals before rounding off to the nearest whole number. Hence, some of the values may not match if calculated using the rounded-off mean values of this summary table. cTA98, TA100, TA1535, TA1537: 2-Aminoanthracene (4 µg/plate) dWP2uvrA(pKM101): 2-Aminoanthracene (30 µg/plate) SD: Standard deviation NA: Not applicable |
TABLE 2. Summary Results of Initial Mutation Assay in the Absence of Metabolic Activation
Treatment (µg/plate) |
No. of revertants/platea |
||||||||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA(pKM101) |
|||||||||||
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
|
SW |
25 |
2 |
NA |
98 |
8 |
NA |
13 |
1 |
NA |
12 |
2 |
NA |
134 |
5 |
NA |
50 |
24 |
3 |
0.96 |
93 |
5 |
0.95 |
13 |
2 |
0.98 |
10 |
1 |
0.86 |
137 |
3 |
1.02 |
158 |
25 |
2 |
1.00 |
95 |
6 |
0.97 |
12 |
1 |
0.90 |
10 |
1 |
0.83 |
132 |
4 |
0.98 |
500 |
24 |
2 |
0.96 |
93 |
5 |
0.95 |
12 |
2 |
0.93 |
9 |
2 |
0.80 |
139 |
5 |
1.04 |
1581 |
23 |
2 |
0.92 |
96 |
5 |
0.98 |
13 |
1 |
0.98 |
10 |
2 |
0.89 |
131 |
5 |
0.98 |
5000 |
24 |
2 |
0.95 |
92 |
5 |
0.94 |
13 |
1 |
0.98 |
10 |
2 |
0.89 |
132 |
7 |
0.98 |
Positive control |
275c |
15c |
10.87c |
576d |
9d |
5.87d |
171d |
21d |
12.80d |
179e |
17e |
15.34e |
578f |
13f |
4.31f |
aValues are means of three replicatescalculated from individual values of Appendix 4and are rounded off to the nearest whole number bRatio of treated/Vehicle control (mean revertants per plate). The presentation was made using the mean values with decimals before rounding off to the nearest whole number. Hence, some of the values may not match if calculated using the rounded-off mean values of this summary table. cTA98: 2-Nitrofluorene (2 µg/plate), dTA100, TA1535: Sodium azide (1 µg/plate) eTA1537: 9-Aminoacridine (50 µg/plate) fWP2uvrA(pKM101): 4-Nitroquinoline-1-oxide (4 µg/plate) SD: Standard deviation NA: Not applicable |
TABLE 3. Summary Results of Confirmatory Mutation Assayin the Presence of Metabolic Activation
Treatment [µg/plate] |
No. of revertants/platea |
||||||||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA (pKM101) |
|||||||||||
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
|
SW |
26 |
3 |
NA |
96 |
3 |
NA |
14 |
1 |
NA |
11 |
2 |
NA |
140 |
8 |
NA |
50 |
25 |
2 |
0.97 |
96 |
9 |
1.00 |
13 |
1 |
0.93 |
11 |
2 |
0.94 |
144 |
5 |
1.03 |
158 |
25 |
3 |
0.95 |
97 |
5 |
1.01 |
12 |
1 |
0.88 |
10 |
2 |
0.91 |
136 |
7 |
0.97 |
500 |
24 |
2 |
0.94 |
89 |
4 |
0.93 |
14 |
1 |
1.00 |
10 |
1 |
0.85 |
132 |
8 |
0.94 |
1581 |
23 |
1 |
0.88 |
98 |
3 |
1.02 |
13 |
1 |
0.93 |
10 |
2 |
0.88 |
132 |
5 |
0.94 |
5000 |
24 |
2 |
0.94 |
95 |
3 |
0.99 |
13 |
1 |
0.93 |
10 |
1 |
0.88 |
142 |
9 |
1.01 |
Positive control |
571c |
26c |
21.95c |
880c |
12c |
9.16c |
182c |
16c |
12.98c |
167c |
21c |
14.76c |
582d |
19d |
4.16d |
aValues are means of three replicatescalculated from individual values of Appendix 5 and are rounded off to the nearest whole number bRatio of treated/Vehicle control (mean revertants per plate). The presentation was made using the mean values with decimals before rounding off to the nearest whole number. Hence, some of the values may not match if calculated using the rounded-off mean values of this summary table. cTA98, TA100, TA1535, TA1537: 2-Aminoanthracene (4 µg/plate) dWP2uvrA(pKM101): 2-Aminoanthracene (30 µg/plate) SD: Standard deviation NA: Not applicable |
TABLE 4. Summary Results of Confirmatory Mutation Assay in the Absence of Metabolic Activation
Treatment [µg/plate] |
No. of revertants/platea |
||||||||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
WP2uvrA (pKM101) |
|||||||||||
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
Mean |
SD |
Ratiob |
|
SW |
26 |
2 |
NA |
98 |
7 |
NA |
14 |
1 |
NA |
11 |
2 |
NA |
145 |
5 |
NA |
50 |
25 |
2 |
0.95 |
99 |
10 |
1.01 |
14 |
2 |
1.00 |
10 |
2 |
0.91 |
143 |
5 |
0.99 |
158 |
25 |
3 |
0.95 |
95 |
6 |
0.96 |
13 |
2 |
0.98 |
10 |
2 |
0.85 |
136 |
6 |
0.94 |
500 |
23 |
2 |
0.90 |
91 |
4 |
0.93 |
13 |
1 |
0.93 |
10 |
1 |
0.88 |
145 |
5 |
1.00 |
1581 |
25 |
3 |
0.97 |
91 |
7 |
0.93 |
13 |
1 |
0.95 |
10 |
1 |
0.85 |
136 |
9 |
0.94 |
5000 |
24 |
2 |
0.92 |
96 |
6 |
0.97 |
13 |
2 |
0.98 |
10 |
2 |
0.91 |
140 |
8 |
0.97 |
Positive control |
272c |
25c |
10.46c |
573d |
22d |
5.82d |
175d |
14d |
12.78d |
184e |
12e |
16.26e |
568f |
20f |
3.92f |
aValues are means of three replicatescalculated from individual values of Appendix 6and are rounded off to the nearest whole number bRatio of treated/Vehicle control (mean revertants per plate). The presentation was made using the mean values with decimals before rounding off to the nearest whole number. Hence, some of the values may not match if calculated using the rounded-off mean values of this summary table. cTA98: 2-Nitrofluorene (2 µg/plate), dTA100, TA1535: Sodium azide (1 µg/plate) eTA1537: 9-Aminoacridine (50 µg/plate) fWP2uvrA(pKM101): 4-Nitroquinoline-1-oxide (4 µg/plate) SD: Standard deviation NA: Not applicable |
Applicant's summary and conclusion
- Conclusions:
- All criteria for a valid study were met as described in the study plan. It is concluded that the test item, Tyzor LA, was not mutagenic in this bacterial reverse mutation test up to the OECD 471-recommended top dose of 5000 µg/plate under the conditions of testing employed.
- Executive summary:
Both the Salmonella typhimurium and Escherichia coli tester strains were found to be reliable and responsive to the different genotypic characterization tests like the amino acid requirement, rfa mutation, uvr mutation and the R-factor plasmids. Similarly, the spontaneous revertant counts of the vehicle control groups of these tester strains were in the ranges of the test facility’s historical control data.
The positive controls produced a more than 3-fold increase in the mean numbers of revertant colonies when compared to the respective vehicle controls, demonstrating the sensitivity of the assay procedure.
The test item at doses up to 5000 µg/plate did not cause a two fold increase in the mean numbers of revertant colonies in the strains TA98, TA100 and WP2uvrA (pKM101) or three fold increase in the mean numbers of revertant colonies in the strains TA1535 and TA1537 either in the presence or absence of the metabolic activation system when compared to the respective vehicle control plates.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.